Cyclin‐dependent kinase inhibitor 2A (CDKN2A), a member of the cyclin‐dependent kinase inhibitors family, exerts its function by inducing cell cycle arrest in the G1 phase, while simultaneously exhibiting hypermethylation characteristics in gastric adenocarcinoma.65 Here, CDKN2A is linked to gastric adenocarcinoma.